Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast

Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated... Targeted Oncology https://doi.org/10.1007/s11523-022-00927-5 COMMENTAR Y Current and Future Perspectives of Health‑Related Quality of Life in Resectable EGFR‑Mutated Non‑Small Cell Lung Cancer: A Podcast 1 2 3 4 Thomas John  · Margarita Majem  · Diane Legg  · Jonathan Goldman Accepted: 25 October 2022 © The Author(s) 2022 Transcript before or after surgery can improve our ability to prevent the cancer from coming back. Most patients will proceed to sur- TJ: Thomas John (medical oncologist; lead presenter) gery first and then get after surgery post-operative or some- JG: Jonathan Goldman (medical oncologist) times called ‘adjuvant’ chemotherapy, usually with two drugs MM: Margarita Majem (medical oncologist) called a platinum-based chemotherapy for stages II and up to DL: Diane Legg (patient advocate) IIIA [2]. There are increasingly the utilization of pre-operative or neoadjuvant chemotherapy, especially chemotherapy with TJ: Hello. Welcome to this podcast on health-related immunotherapy, for some patients [2–4]. However, for many, quality of life in resectable EGFR-mutant non-small cell the standard remains surgery followed by chemotherapy [2]. lung cancer current and future perspectives. My name is Despite some significant advances, the outcomes remain poor Thomas John, I’m a medical oncologist and researcher at the [3–5] and there is significant and important research underway Department of Medical Oncology, Peter MacCallum Can- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Targeted Oncology Springer Journals

Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast

Download PDF
8 pages

Loading next page...
 
/lp/springer-journals/current-and-future-perspectives-of-health-related-quality-of-life-in-Tj9hMiWUgL

References (33)

Publisher
Springer Journals
Copyright
Copyright © The Author(s) 2022
ISSN
1776-2596
eISSN
1776-260X
DOI
10.1007/s11523-022-00927-5
Publisher site
See Article on Publisher Site

Abstract

Targeted Oncology https://doi.org/10.1007/s11523-022-00927-5 COMMENTAR Y Current and Future Perspectives of Health‑Related Quality of Life in Resectable EGFR‑Mutated Non‑Small Cell Lung Cancer: A Podcast 1 2 3 4 Thomas John  · Margarita Majem  · Diane Legg  · Jonathan Goldman Accepted: 25 October 2022 © The Author(s) 2022 Transcript before or after surgery can improve our ability to prevent the cancer from coming back. Most patients will proceed to sur- TJ: Thomas John (medical oncologist; lead presenter) gery first and then get after surgery post-operative or some- JG: Jonathan Goldman (medical oncologist) times called ‘adjuvant’ chemotherapy, usually with two drugs MM: Margarita Majem (medical oncologist) called a platinum-based chemotherapy for stages II and up to DL: Diane Legg (patient advocate) IIIA [2]. There are increasingly the utilization of pre-operative or neoadjuvant chemotherapy, especially chemotherapy with TJ: Hello. Welcome to this podcast on health-related immunotherapy, for some patients [2–4]. However, for many, quality of life in resectable EGFR-mutant non-small cell the standard remains surgery followed by chemotherapy [2]. lung cancer current and future perspectives. My name is Despite some significant advances, the outcomes remain poor Thomas John, I’m a medical oncologist and researcher at the [3–5] and there is significant and important research underway Department of Medical Oncology, Peter MacCallum Can-

Journal

Targeted Oncology – Springer Journals

Published: Jan 1, 2023

There are no references for this article.